Your browser doesn't support javascript.
loading
Constructing an ethical framework for priority allocation of pandemic vaccines.
Fielding, J; Sullivan, S G; Beard, F; Macartney, K; Williams, J; Dawson, A; Gilbert, G L; Massey, P; Crooks, K; Moss, R; McCaw, J M; McVernon, J.
Afiliación
  • Fielding J; Victorian Infectious Diseases Laboratory Epidemiology Unit, The University of Melbourne and Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity Melbourne, Australia.
  • Sullivan SG; World Health Organization Collaborating Centre for Reference & Research on Influenza, Royal Melbourne Hospital, and Doherty Department, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
  • Beard F; National Centre for Immunisation Research and Surveillance, Sydney Children's Hospitals Network, Westmead, Australia; School of Public Health, University of Sydney, Sydney, Australia.
  • Macartney K; National Centre for Immunisation Research and Surveillance, Sydney Children's Hospitals Network, Westmead, Australia; Discipline of Child and Adolescent Health, University of Sydney, Sydney, Australia.
  • Williams J; Sydney Health Ethics, School of Public Health, University of Sydney, Sydney, Australia.
  • Dawson A; Sydney Health Ethics, School of Public Health, University of Sydney, Sydney, Australia; Marie Bashir Institute for Emerging Infections and Biosecurity, University of Sydney, Sydney, Australia.
  • Gilbert GL; Sydney Health Ethics, School of Public Health, University of Sydney, Sydney, Australia; Marie Bashir Institute for Emerging Infections and Biosecurity, University of Sydney, Sydney, Australia.
  • Massey P; Hunter New England Local Health District, Population Health, Wallsend, New South Wales, Australia; College of Medicine and Dentistry, James Cook University, Townsville, Australia.
  • Crooks K; Hunter New England Local Health District, Population Health, Wallsend, New South Wales, Australia; Menzies School of Health Research, Charles Darwin University, Casuarina, Darwin, Northern Territory, Australia.
  • Moss R; Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Melbourne Australia.
  • McCaw JM; Victorian Infectious Diseases Laboratory Epidemiology Unit, The University of Melbourne and Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity Melbourne, Australia; Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Mel
  • McVernon J; Victorian Infectious Diseases Laboratory Epidemiology Unit, The University of Melbourne and Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity Melbourne, Australia; Modelling and Simulation Unit, Melbourne School of Population and Global Health, The University of Mel
Vaccine ; 39(5): 797-804, 2021 01 29.
Article en En | MEDLINE | ID: mdl-33408013
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Pandemias Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Pandemias Tipo de estudio: Prognostic_studies / Qualitative_research / Risk_factors_studies País/Región como asunto: Oceania Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article País de afiliación: Australia